no cases reported since 2019, contradicting his own department head
In Kanpur, fourteen children being treated for thalassemia have tested positive for HIV, Hepatitis B, or Hepatitis C following blood transfusions — a revelation that has since been denied by the very institution at the center of it. When a hospital's principal contradicts its own pediatrics chief and moves to silence him, the question shifts from what happened to who is permitted to say so. The children's infections, whatever their origin, now exist in the shadow of an institutional dispute over narrative control — a reminder that in medicine, as in power, the management of truth can become its own emergency.
- Fourteen children with thalassemia tested positive for HIV and hepatitis after receiving blood transfusions — a cluster of infections serious enough to demand immediate investigation.
- The hospital's own pediatrics chief confirmed the cases to the press, citing the 'window period' as a likely explanation for how infected blood evaded standard screening.
- Days later, the medical college principal flatly denied any such cases had occurred since 2019, directly contradicting his colleague and throwing the institution into open contradiction.
- Rather than launching a transparent inquiry, the principal moved to discipline the pediatrics head for speaking to the media without authorization — prioritizing institutional control over accountability.
- The families of the fourteen children are left without answers: whether blood was properly tested, whether protocols were followed, and whether anyone will be held responsible remains unresolved.
On a Monday in Kanpur, a newspaper reported that fourteen children — all suffering from thalassemia, all dependent on regular blood transfusions — had tested positive for HIV, Hepatitis B, or Hepatitis C. By Wednesday, the principal of the medical college overseeing their hospital was saying it never happened.
Arun Arya, head of pediatrics at Lala Lajpat Rai Hospital, had spoken first. Seven children carried Hepatitis B, he said. Five had Hepatitis C. Two had HIV. He offered a clinical explanation: the infections may have slipped through during the 'window period' — that narrow interval after a virus enters the body but before standard antibody tests can detect it. The Elisa test, which screens donated blood for HIV and hepatitis, typically cannot identify an infection until roughly forty-five days after exposure. A more sensitive method exists, but even it is not infallible.
Then came the denial. Principal Sanjay Kala stated that no HIV or hepatitis cases had been identified at the hospital since 2019, and that the children — who had received transfusions at both private and public facilities across Uttar Pradesh — had shown nothing in their regular screenings. He then recommended disciplinary action against Arya for speaking to the press without authorization.
The contradiction is not merely administrative. If fourteen children from different parts of the state contracted these infections around the same time, the window period alone may not explain it. Were all blood units properly tested? Were protocols followed at every facility involved? The hospital's response — silencing the doctor who raised the alarm — suggests an institution more focused on protecting its reputation than on finding answers for the families whose children now carry these diagnoses.
On Monday, a newspaper reported something that would shake a hospital in Kanpur: fourteen children, all suffering from thalassemia and all in need of blood transfusions, had tested positive for HIV, Hepatitis B, or Hepatitis C. By Wednesday, the principal of the medical college overseeing that hospital was saying it never happened.
Sanjay Kala, who heads Ganesh Shankar Vidyarthi Medical College, flatly denied the Hindustan Times account. He stated that no cases of HIV or hepatitis had been identified at the affiliated Lala Lajpat Rai Hospital since 2019. The children in question—who came from different parts of Uttar Pradesh and had received transfusions at both private and public facilities—were screened regularly at the hospital, he said, and none had tested positive during those screenings.
But just days earlier, Arun Arya, the head of pediatrics at that same hospital, had told the same newspaper a different story. Seven children had tested positive for Hepatitis B, he said. Five more carried Hepatitis C. Two had HIV. Arya offered a technical explanation: the infections might have slipped through because they occurred during what medical professionals call the window period—that narrow stretch of time after a virus enters the body but before the body has produced enough antibodies for standard screening tests to catch it.
The contradiction was stark, and Kala's response was swift. On Wednesday, he recommended action against Arya for speaking to the media without authorization. The message was clear: the hospital's narrative would be controlled from above.
Understanding why this matters requires knowing how blood screening actually works. When someone donates blood, it must be tested for HIV and hepatitis before it can be used in a transfusion. The standard test, called Elisa, looks for antibodies—the immune system's response to infection. But there is a catch. If a donor was infected very recently, their body may not have generated enough antibodies yet for Elisa to detect. The test typically cannot identify an infection until forty-five days after exposure. A more sensitive method, nucleic acid amplification testing, can narrow that window to ten or fifteen days, but even that is not foolproof.
National guidelines require that every unit of donated blood undergo screening. Yet experts acknowledge that most transfusion-related infections occur precisely because these tests miss fresh infections—or because testing is skipped altogether. The window period is not a flaw in the system; it is a known limitation that hospitals and blood banks must manage carefully.
What happened in Kanpur raises questions that a denial does not answer. Were the children screened before receiving transfusions? Were all units of blood tested? Were the tests performed at the hospitals where the transfusions occurred, or elsewhere? And if fourteen children from different parts of the state all contracted these infections around the same time, was it truly just the window period, or was something else at play?
Kala's move to silence Arya suggests the hospital is more concerned with managing its reputation than with investigating what went wrong. For the families of these fourteen children, the institutional finger-pointing offers no answers about how their children came to carry these infections, or what comes next.
Citações Notáveis
During screening, not even a single patient with HIV or hepatitis infection has been found here since 2019— Sanjay Kala, principal of Ganesh Shankar Vidyarthi Medical College
Seven children tested positive for Hepatitis B, five for Hepatitis C, and two for HIV; infections may have occurred during the window period when viruses evade detection— Arun Arya, head of pediatrics at Lala Lajpat Rai Hospital
A Conversa do Hearth Outra perspectiva sobre a história
Why would a hospital principal deny something a department head just confirmed?
Control. Once the story is public, the institution's instinct is to contain it—to say it didn't happen, or that it's being misunderstood. Admitting a problem means accountability, investigations, maybe lawsuits.
But the pediatrics head was there. He examined the children. He has the test results.
He does. But he's also subordinate. When the principal says he wasn't authorized to speak to the media, that's a way of saying: your job is to treat patients, not talk to reporters. It's a power move dressed up as protocol.
Is the window period a real explanation, or an excuse?
It's real—it's a genuine limitation of how we screen blood. But it's also convenient. It explains away the infections without requiring anyone to investigate whether the screening was done properly, or whether corners were cut.
What would proper investigation look like?
You'd trace each child's transfusion back to its source. Which hospital? Which blood bank? Were the units tested? When? With which test? You'd look at whether the hospital followed national guidelines. You'd interview staff. You'd ask hard questions. But that takes time and creates liability.
So the denial might be the beginning of a cover-up?
It might be. Or it might just be institutional panic. Either way, it tells you that transparency isn't the priority right now.